Λίστα αντικειμένων
Presenter: Prof. Spyridonidis
Participants: Dr Liga, Dr Tsokanas, Sagiadinou E., Christopoulou A., Panagi Z.
Post-transplant cyclophosphamide (PTCY) is increasingly used for allogeneic peripheral blood stem cell transplantation (allo-PBSCT) from an HLA-matched unrelated donor (MUD) as an alternative to the standard anti-thymocyte globulin (ATG) graft-versus-host disease (GvHD) prophylaxis. Following the demonstration that the use of PBSC
haploidentical grafts results in more GvHD than bone marrow grafts, groups have attempted to reduce GvHD in haploidentical-PBSCT by adding ATG to PTCY. The experience of combined PTCY+ATG in the MUD allo-PBSCT is minimal and whether ATG brings any added value when PTCY is used in this setting is still unclear.
Though addition of ATG does not seem to provide any extra benefit in terms of further GVHD reduction when a PTCY regimen is used, our results indicate that such a dual PTCY+ATG based GVHD prophylaxis is a feasible strategy in MUD allo-PBSCT without detrimental effect on AML control. Future studies should evaluate the optimal dose and timing for the PTCY+ATG combination
Participants: Dr Liga, Dr Tsokanas, Sagiadinou E., Christopoulou A., Panagi Z.
Post-transplant cyclophosphamide (PTCY) is increasingly used for allogeneic peripheral blood stem cell transplantation (allo-PBSCT) from an HLA-matched unrelated donor (MUD) as an alternative to the standard anti-thymocyte globulin (ATG) graft-versus-host disease (GvHD) prophylaxis. Following the demonstration that the use of PBSC
haploidentical grafts results in more GvHD than bone marrow grafts, groups have attempted to reduce GvHD in haploidentical-PBSCT by adding ATG to PTCY. The experience of combined PTCY+ATG in the MUD allo-PBSCT is minimal and whether ATG brings any added value when PTCY is used in this setting is still unclear.
Though addition of ATG does not seem to provide any extra benefit in terms of further GVHD reduction when a PTCY regimen is used, our results indicate that such a dual PTCY+ATG based GVHD prophylaxis is a feasible strategy in MUD allo-PBSCT without detrimental effect on AML control. Future studies should evaluate the optimal dose and timing for the PTCY+ATG combination